NAQUA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Naqua, and what generic alternatives are available?
Naqua is a drug marketed by Schering and is included in one NDA.
The generic ingredient in NAQUA is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAQUA?
- What are the global sales for NAQUA?
- What is Average Wholesale Price for NAQUA?
Summary for NAQUA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Patent Applications: | 3,748 |
| DailyMed Link: | NAQUA at DailyMed |
US Patents and Regulatory Information for NAQUA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | NAQUA | trichlormethiazide | TABLET;ORAL | 012265-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Schering | NAQUA | trichlormethiazide | TABLET;ORAL | 012265-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
